Retrieve available abstracts of 326 articles: HTML format
Single Articles
July 2025
HU A, Wen X, Tian J, Wang Z, et al RET fusion rather than BRAF mutation confers a higher risk of aggressiveness and
recurrence in papillary thyroid carcinoma.
Oral Oncol. 2025;167:107464. PubMedAbstract available
RIJKEN JA, de Ridder M, Devriese LA, Breimer GE, et al Long-term survival after multimodal treatment of sinonasal NUT carcinoma: a case
report.
Oral Oncol. 2025;166:107392. PubMedAbstract available
RONDI P, Mattavelli D, Rampinelli V, Schreiber A, et al The role of volumetry in sinonasal cancer response assessment to induction
chemotherapy, results from two phase II non-randomized controlled prospective
multicentric trials: SINTART-1 and SINTART-2.
Oral Oncol. 2025;166:107388. PubMedAbstract available
SOMAY E, Bascil S, Topkan E, Selek U, et al Re: "Computed tomography radiomics-based cross-sectional detection of mandibular
osteoradionecrosis in head and neck cancer survivors" by Kamel et al.
Oral Oncol. 2025;167:107457. PubMed
June 2025
MALGAVE DS, Hartman CM, Kramer JR, Richardson PA, et al Impact of HIV status on overall survival in head and neck cancers by anatomical
site and stage: A multi-center cohort study.
Oral Oncol. 2025;167:107446. PubMedAbstract available
RAJATHIRAJAN SD Commentary on, "Optimal induction chemotherapy courses in nasopharyngeal
carcinoma in the IMRT era: A recursive partitioning risk stratification analysis
based on EBV DNA and AJCC staging".
Oral Oncol. 2025;167:107453. PubMed
CHENG HS, Lin TY, Twu CW, Lin PJ, et al Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors,
and survival impact: Running title: Massive nasal bleeding in NPC.
Oral Oncol. 2025;167:107456. PubMedAbstract available
DAUNGSUPAWONG H, Wiwanitkit V Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT
era: Comment.
Oral Oncol. 2025;167:107454. PubMed
SAMUEL CHAN SW, Amer Al Maqrashi ZA, Kim DH, Choi D, et al Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in
incurable advanced head and neck squamous cell carcinoma: A case-series.
Oral Oncol. 2025;167:107439. PubMed
NGO DQ, Truong DS, Le DT, Hoang TM, et al Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid
carcinoma: surgical and oncological outcomes.
Oral Oncol. 2025;167:107406. PubMedAbstract available
ARAUJO M, Bouassaly J, Farshadi F, Hier M, et al Current status of circulating tumor DNA and circulating cell alterations in
HPV-associated head and neck cancer.
Oral Oncol. 2025;167:107417. PubMedAbstract available
KAMEL S, Humbert-Vidan L, Kaffey Z, Mirbahaeddin S, et al Computed tomography radiomics-based cross-sectional detection of mandibular
osteoradionecrosis in head and neck cancer survivors.
Oral Oncol. 2025;167:107337. PubMedAbstract available
MAK CH, Cao LM, Luo HY, Zhou K, et al Postoperative complications of neck dissection for head and neck squamous cell
carcinoma: a systematic review and meta-analysis.
Oral Oncol. 2025;167:107430. PubMedAbstract available
YANG X, Li R Reconsidering the prognostic value of HRQOL in head and neck cancer.
Oral Oncol. 2025;167:107421. PubMed
YAN Y, Wang Z, Sun Y Comment on: Margins do not impact recurrence and survival in advanced laryngeal
cancer-A retrospective cohort analysis.
Oral Oncol. 2025;167:107427. PubMed
LIANG YJ, Luo MJ, Wen DX, Wang P, et al Optimal induction chemotherapy courses in nasopharyngeal carcinoma in the IMRT
era: A recursive partitioning risk stratification analysis based on EBV DNA and
AJCC staging.
Oral Oncol. 2025;167:107404. PubMedAbstract available
KIM MJ, Koo BS, Cho KJ, Lee SH, et al Health-related quality-of-life assessment in patients with oropharyngeal cancer:
A comparison of EQ-5D-5L and EORTC instruments.
Oral Oncol. 2025;165:107342. PubMedAbstract available
GARSET-ZAMANI M, Makouei F, Agander TK, Lelkaitis G, et al Feasibility of 3D ultrasound for intraoperative tumor margin assessment in
transoral robotic surgery for oropharyngeal squamous cell carcinoma: A pilot
study.
Oral Oncol. 2025;165:107330. PubMedAbstract available
KUMARI S, Mishra S, Ali W, Singh US, et al Implication of circulating miRNAs as potential diagnostic biomarker in
oropharyngeal squamous cell Carcinoma: Association with Human Papilloma Virus.
Oral Oncol. 2025;165:107305. PubMedAbstract available
JANG HB, Lee DH, Lim SC Treatment outcomes of sinonasal adenoid cystic carcinoma: a single-center
experience.
Oral Oncol. 2025;165:107317. PubMedAbstract available
CHELVARAJAH RC, Liu Y, Su J, Abdalaty AH, et al Factors associated with detection of oligometastatic recurrence and outcome
following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.
Oral Oncol. 2025;165:107310. PubMedAbstract available
May 2025
HINTZE JM, Cleere E, Soo A, Timon C, et al Margins do not impact recurrence and survival in advanced laryngeal cancer - A
retrospective cohort analysis.
Oral Oncol. 2025;167:107402. PubMedAbstract available
BAIJU DC, Ravi J, Sarma M, Sureshan M, et al Detection of hotspot mutations in oral cancer through Ion AmpliSeq cancer
hotspot panel v.2.0: A circulating DNA fragmentomics approach in the Northeast
Indian population.
Oral Oncol. 2025;166:107387. PubMedAbstract available
JEYARAJ G Commentary on, "The association between health-related quality of life and
five-year overall survival among head and neck cancer patients: A prospective
cohort study".
Oral Oncol. 2025;166:107401. PubMed
LIU X, Xue S Comment on: Risk factors of lymph node metastasis in the diffuse sclerosing
variant of papillary thyroid carcinoma compared with conventional papillary
thyroidcarcinoma in pediatric populations.
Oral Oncol. 2025;166:107368. PubMed
VERDONCK-DE LEEUW IM, Lissenberg-Witte BI, de Bree R, Buffart LM, et al The association between health-related quality of life and five-year overall
survival among head and neck cancer patients: A prospective cohort study.
Oral Oncol. 2025;166:107367. PubMedAbstract available
OLSON B, Bogan A, Abdel-Halim CN, Rolle-McFarland D, et al Identification of clinical and pathologic features associated with extranodal
extension in patients with HPV-mediated oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;166:107308. PubMedAbstract available
TONSBEEK AM, van der Lely JN, Bulstra L, Venema J, et al Long-term health-related quality of life in oral cancer survivors following
microvascular tongue reconstruction.
Oral Oncol. 2025;166:107363. PubMedAbstract available
MALI SB Corrigendum to "Review of STAT3 (Signal Transducers and Activators of
Transcription) in head and neck cancer" [Oral Oncol. 51 (2015) 565-569].
Oral Oncol. 2025 May 10:107357. doi: 10.1016/j.oraloncology.2025.107357. PubMed
MALI SB Corrigendum to "RNA interference in oral cancer" [Oral Oncol. 51 (2015) e2-e3].
Oral Oncol. 2025 May 9:107358. doi: 10.1016/j.oraloncology.2025.107358. PubMed
SHAIKH N, Pandey M, Manna S, Gawde J, et al Evaluating the prognostic value of tumor-derived circulating endothelial cells
and their progenitors in platinum-refractory oral cancer patients for response to
triple metronomic therapy.
Oral Oncol. 2025;165:107346. PubMedAbstract available
COSTANTINO A, Haughey BH, Alamoudi U, Magnuson JS, et al Prognostic significance of distant metastasis site at diagnosis in HPV-related
oropharyngeal cancer.
Oral Oncol. 2025;165:107361. PubMedAbstract available
ONAGA R, Enokida T, Kuno H, Hiyama T, et al Significance of imaging-detected extranodal extension in locally advanced
squamous cell carcinoma of the head and neck treated with induction chemotherapy
followed by chemoradiotherapy.
Oral Oncol. 2025;165:107351. PubMedAbstract available
ZHU X, Xu H, Zhao Y, Diao W, et al Single-cell transcriptomics reveal the effects of chemoimmunotherapy on
hypopharyngeal cancer and its tumor microenvironment.
Oral Oncol. 2025;165:107347. PubMedAbstract available
PEI Y, Yang Z, Mao Y, Chen X, et al Evolving dynamics in clinical trials for oral cancer: Trends, treatment
modalities, and future directions.
Oral Oncol. 2025;165:107333. PubMedAbstract available
XIAO X, Liu T, Lu M, Song Z, et al Comment on the role of lymph node level ratio in predicting prognosis of pN1 head
and neck squamous cell carcinoma.
Oral Oncol. 2025;165:107344. PubMed
CHENNAREDDY S, Chen S, Levinson C, Genden EM, et al Circulating tumor DNA in human papillomavirus-associated oropharyngeal cancer
management: A systematic review.
Oral Oncol. 2025;164:107262. PubMedAbstract available
MARCHI F, Del Bon F, Chu F, Sampieri C, et al Refining prognostic subcategories in intermediate-advanced glottic cancer: A
multicentric study on 637 patients treated by transoral laser microsurgery.
Oral Oncol. 2025;164:107264. PubMedAbstract available
CANALI L, Russo E, Pangallo S, Bussu F, et al Regional disease control in nasal vestibule squamous cell carcinoma: Systematic
review and meta-analysis.
Oral Oncol. 2025;164:107270. PubMedAbstract available
MOTTA G, Magno C, Castagna L, De Berardinis T, et al Endoscope-assisted trans-oral approach (EATA) to remove a rare pleomorphic
adenoma of the nasopharynx.
Oral Oncol. 2025;164:107260. PubMedAbstract available
BEDDOK A, Popovtzer A, Calugaru V, Fontaine M, et al Proton therapy for primary and recurrent HPV-related oropharyngeal cancer.
Oral Oncol. 2025;165:107309. PubMedAbstract available
April 2025
MALI SB Corrigendum to "Proteomics for oral cancer" [Oral Oncol. 50(11) (2014) e67].
Oral Oncol. 2025 Apr 30:107338. doi: 10.1016/j.oraloncology.2025.107338. PubMed
CITRO S, Ghiani L, Doni M, Miccolo C, et al HPV-mediated PARP1 regulation and drug sensitization in head and neck cancer.
Oral Oncol. 2025;165:107307. PubMedAbstract available
SILVA CUNHA JL Comment on "Histological tumor necrosis predicts decreased survival after
neoadjuvant chemotherapy in head and neck squamous cell carcinoma".
Oral Oncol. 2025;165:107336. PubMed
AL FADEL AM, Jakobsen KK, Jensen LH, Carlander AF, et al The epidemiological trends and survival of HPV-related oropharyngeal cancer other
than tonsils and base of tongue - a systematic review and meta-analysis.
Oral Oncol. 2025;165:107311. PubMedAbstract available
ARDILA CM Enhancing the scope and impact of photobiomodulation research in head and neck
cancer therapy.
Oral Oncol. 2025;165:107303. PubMed
JEYARAJ G Commentary on, "Molecular features of T and N stage progression in laryngeal
cancer.".
Oral Oncol. 2025;165:107331. PubMed
BARCELONA MVN, Waldron J, Sullivan BO, Su J, et al Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily
managed with concurrent chemo-radiotherapy.
Oral Oncol. 2025;165:107299. PubMedAbstract available
YAO CMKL, Hueniken K, Huang SH, Liu G, et al Development of a patient reported outcomes based machine learning model to
predict recurrences in head and neck cancer.
Oral Oncol. 2025;165:107304. PubMedAbstract available
JEYARA G Commentary on, "Risk factors and a risk assessment model for venous
thromboembolism in head and neck cancer surgery.".
Oral Oncol. 2025;165:107320. PubMed
ZHOU P, Zhu Y, Xu B, Jiang X, et al Cavernous sinus syndrome in a patient with occult nasopharyngeal carcinoma: A
diagnostic challenge.
Oral Oncol. 2025;165:107316. PubMedAbstract available
COSTANTINO A, Sampieri C, Haughey BH, Alamoudi U, et al Adjuvant treatment in elderly patients undergoing transoral surgery for
HPV-related oropharyngeal cancer.
Oral Oncol. 2025;165:107312. PubMedAbstract available
KOSKENNIEMI AR, Huusko T, Routila J, Jalkanen S, et al Histological tumor necrosis predicts decreased survival after neoadjuvant
chemotherapy in head and neck squamous cell carcinoma.
Oral Oncol. 2025;165:107287. PubMedAbstract available
JEYARAJ G Commentary on, "Effect of Enhanced Recovery After Radiotherapy (ERAR) on the
quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A
randomized controlled trial".
Oral Oncol. 2025;165:107302. PubMed
LI N, Zeng PYF, Kim HAJ, Karimi A, et al Molecular features of T and N stage progression in laryngeal cancer.
Oral Oncol. 2025;165:107283. PubMedAbstract available
BURGER AVM, Koot MA, van Balen DEM, Schaeffers AWMA, et al Comparison of cisplatin-induced hearing loss in different durations of infusion
and volume of hydration schedules in head and neck squamous cell carcinoma
patients treated with cisplatin-based chemoradiation.
Oral Oncol. 2025;164:107246. PubMedAbstract available
HANNA GJ, Zheng D, Gao W, Hair GM, et al Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck
squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].
Oral Oncol. 2025 Apr 11:107292. doi: 10.1016/j.oraloncology.2025.107292. PubMed
MA J, Brooks C, Tasoulas J, Wind LS, et al Revisiting the use of capecitabine in the era of immunotherapy: Efficacy as
second-line and later therapy in recurrent/metastatic head and neck squamous cell
carcinoma.
Oral Oncol. 2025;164:107293. PubMed
SLATER NN, Herberger L, Farsi S, Rogers AL, et al Assessing barriers to adjuvant therapy among patients with head and neck cancer
in Arkansas.
Oral Oncol. 2025;164:107290. PubMedAbstract available
XIAO J, You M, Song Y, Gao R, et al Risk factors and a risk assessment model for venous thromboembolism in head and
neck cancer surgery.
Oral Oncol. 2025;164:107288. PubMedAbstract available
VIANNA CAMOLESI GC, Prado-Pena IB, Gomez-Caamano A, Victoria-Fernandez C, et al Photobiomodulation for the prevention of oral side effects secondary to head and
neck cancer therapy: results of a randomised, single-blind clinical trial.
Oral Oncol. 2025;164:107266. PubMedAbstract available
JEYARAJ G Commentary on, "Evaluation of a comprehensive set of normal tissue complication
probability models for patients with head and neck cancer in an international
cohort".
Oral Oncol. 2025;164:107285. PubMed
ROSING F, Plath M, Proctor T, Hofler D, et al Post-treatment monitoring of surgically treated oropharyngeal squamous cell
carcinoma patients using human papillomavirus cell-free DNA.
Oral Oncol. 2025;163:107225. PubMedAbstract available
March 2025
LIN N, Zhou X, Wang Y, Zhou J, et al Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in
patients with nasopharyngeal carcinoma after radiotherapy: A randomized
controlled trial.
Oral Oncol. 2025;164:107269. PubMedAbstract available
JEYARAJ G Commentary on, "Thyroid volumes after intensity-modulated radiotherapy as
predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma: A
retrospective study".
Oral Oncol. 2025;163:107256. PubMed
ARDILA CM, Yadalam PK AI-driven histopathologic insights in HPV-positive head and neck squamous cell
carcinomas.
Oral Oncol. 2025;163:107261. PubMed
MATHEW JM, Busca I, Baskurt Z, Giuliani M, et al Changes in unmet needs after treatment for head and neck cancers - A prospective
longitudinal cohort study.
Oral Oncol. 2025;163:107250. PubMedAbstract available
DONG Z, Wang GY, Qin GJ, Dai DY, et al Thyroid volumes after intensity-modulated radiotherapy as predictors of
radiation-induced hypothyroidism in nasopharyngeal carcinoma: A retrospective
study.
Oral Oncol. 2025;163:107223. PubMedAbstract available
LORENZ FJ, Kharouta M, Mahase SS, Goyal N, et al Hospital-Based Registry Analysis of Staging Efficacy and Proposed Staging
Subclassification for Stage I HPV-Associated Oropharyngeal Squamous Cell
Carcinoma.
Oral Oncol. 2025;163:107251. PubMedAbstract available
PETRELLI F, Lorini L, Paderno A, Carioli D, et al Treatment of primary tumor in metastatic head and neck Carcinoma: A systematic
review and Meta-Analysis.
Oral Oncol. 2025;163:107248. PubMedAbstract available
HIEROMNIMON HM, Trzcinska A, Wen FT, Howard FM, et al Analysis of AI foundation model features decodes the histopathologic landscape of
HPV-positive head and neck squamous cell carcinomas.
Oral Oncol. 2025;163:107207. PubMedAbstract available
GAZZINI L, Festa BM, Calabrese L Elective neck dissection: Are we bound to outdated concepts?
Oral Oncol. 2025;163:107245. PubMed
WU WJ, An PG, Liu Q, Zhang ZQ, et al Neoadjuvant chemoimmunotherapy brings superior quality of life of patients with
locally advanced oral or oropharyngeal cancer: A propensity score-matched
analysis.
Oral Oncol. 2025;162:107218. PubMedAbstract available
YANG F, Peng W, Wei H, Li X, et al Model-free parameters derived from intravoxel inherent motion combined with tumor
aggressiveness indicators in predicting 5-year treatment outcome in NPC.
Oral Oncol. 2025;162:107187. PubMedAbstract available
YE Z, Li X, Xie F, Sun J, et al A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT
carcinoma.
Oral Oncol. 2025;162:107185. PubMedAbstract available
CHARLTON A, Mughal Z, Sharin F, Sahota RB, et al Prevalence of synchronous bilateral/contralateral tonsil carcinoma: A systematic
review and meta-analysis.
Oral Oncol. 2025;162:107180. PubMedAbstract available
DE VETTE SPM, van Rijn-Dekker MI, Van den Bosch L, Keijzer K, et al Evaluation of a comprehensive set of normal tissue complication probability
models for patients with head and neck cancer in an international cohort.
Oral Oncol. 2025;163:107224. PubMedAbstract available
MIYAGUCHI J, Shiga K, Katagiri K, Saito D, et al Efficacy of boron neutron capture therapy (BNCT) for patients with oral cancer.
Oral Oncol. 2025;163:107228. PubMedAbstract available
February 2025
WICZUK-WICZEWSKA M, Bernaciak J, Nogal P, Bugaj A, et al Squamous cell carcinoma in the posterior larynx: A rare localization of
supraglottic T1 laryngeal cancer. Case report.
Oral Oncol. 2025;163:107227. PubMedAbstract available
JEYARAJ G Letter to the editor, "Mitoxantrone hydrochloride liposome injection for the
treatment of Recurrent/Metastatic head and neck squamous cell carcinoma: A
multicenter, open-label, single-arm, phase 1b study.".
Oral Oncol. 2025;163:107231. PubMed
TINO RB, Roach MA, Fuentes GD, Agrawal A, et al Response to recent comments on "Development and clinical implementation of a
digital workflow utilizing 3D-printed oral stents for patients with head and neck
cancer receiving radiotherapy".
Oral Oncol. 2025;162:107220. PubMed
MEEKER BS MO, Katragadda A, Alsavaf MB, Birkenbeuel J, et al Dysphagia in head and neck cancer patients with evidence of esophageal
dysmotility on manometry.
Oral Oncol. 2025;162:107219. PubMedAbstract available
YANG H, Sun P, Wang Y, Wang X, et al Mitoxantrone hydrochloride liposome injection for the treatment of
Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter,
Open-label, Single-arm, phase 1b study.
Oral Oncol. 2025;162:107211. PubMedAbstract available
IQBAL MS, West N, Kovarik J, Jackson M, et al Effective, efficient palliative radiotherapy for advanced head and neck cancer:
Real world data using 25 Gy in 5 fractions.
Oral Oncol. 2025;162:107214. PubMed
KHAN A, Pillay M, Bipath R, Msimang M, et al Evolution of testing for the diagnosis of human papillomavirus (HPV) status in
head and neck squamous cell carcinoma: Where from and where to?
Oral Oncol. 2025;162:107208. PubMedAbstract available
MO Y, Wei Y, Liang L, Wu T, et al Clinical significance of post-chemoradiotherapy 2-[(18)F]FDG PET/CT response in
locally advanced nasopharyngeal carcinoma: A real-world study.
Oral Oncol. 2025;161:107160. PubMedAbstract available
LOUBIERES C, Baudouin R, Circiu M, Couineau F, et al Functional and oncological outcomes of transoral laser versus robotic surgery in
supraglottic squamous cell carcinoma.
Oral Oncol. 2025;161:107178. PubMedAbstract available
PERSHAD AR, Ferraro T, Shaver TB, Lee E, et al Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy
for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer.
Oral Oncol. 2025;161:107139. PubMedAbstract available
FENG ZK, Wu WB, Zou RC, Zhang JZ, et al Postradiotherapy nasopharyngeal necrosis with granulation mass: Insights from a
multicentre study.
Oral Oncol. 2025;161:107170. PubMedAbstract available
LYU SI, Fretter C, Eckel HNC, Knipper K, et al High expression of H2AX/gamma-H2AX is associated with distinct biological pathway
alterations and shorter survival in oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;161:107171. PubMedAbstract available
KWON JJ, Milner TD, Kurten C, Pang EH, et al Towards transcervical ultrasound-guided transoral robotic surgery.
Oral Oncol. 2025;161:107167. PubMedAbstract available
SUCHAN M, Wuerdemann N, Wagner S, Langer C, et al Histological and genetic criteria define a clinically relevant subgroup of
HPV-positive oropharyngeal carcinoma.
Oral Oncol. 2025;162:107209. PubMedAbstract available
January 2025
WENGER TA, Gao J, Nurimba M, Phung PG, et al Palliative care utilization among head and neck cancer patients: A
population-based analysis.
Oral Oncol. 2025;162:107205. PubMedAbstract available
CHEN L, Fang R, Cai Z, Huang B, et al CD271(high) cancer stem cells regulate macrophage polarization in head and neck
squamous cell carcinoma.
Oral Oncol. 2025;162:107181. PubMedAbstract available
YIN Z, Zhao H, Zhu C, Fang J, et al Comment on: Development and clinical implementation of a digital workflow
utilizing 3D-printed oral stents for patients with head and neck cancer receiving
radiotherapy.
Oral Oncol. 2025;161:107195. PubMed
JIANG H, Zhou L, Zhao T, Zou G, et al Anaplastic thyroid carcinoma in a 43-year-old female confirmed by metastatic
lymph node pathology: A case report.
Oral Oncol. 2025;161:107192. PubMed
JIANG H, Zhou L, Zou G, Zhang H, et al Synchronous papillary and medullary thyroid carcinoma with distinct genetic
mutations: A case report.
Oral Oncol. 2025;161:107191. PubMed
LI MH, Hu YJ, Shan HM, Gao XL, et al The role of lymph node level ratio in predicting prognosis and the benefits of
postoperative radiotherapy in patients with pathological N1 stage head and neck
squamous cell carcinoma.
Oral Oncol. 2025;161:107193. PubMedAbstract available
HUTTINGER ZM, Gogineni E, Baliga S, Blakaj DM, et al Circulating tumor DNA determines induction chemotherapy response in HPV
associated oropharyngeal squamous cell carcinoma: A pilot study.
Oral Oncol. 2025;161:107179. PubMedAbstract available
TOPKAN E, Somay E, Selek U Commentary on "Induction chemotherapy for locally advanced nasopharyngeal
carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF".
Oral Oncol. 2025;161:107175. PubMed
SENYUREK S, Durankus NK, Selek U, Topkan E, et al Comment on "The effect of time from surgery to commencing adjuvant radiotherapy
for patients with head and neck squamous cell carcinoma".
Oral Oncol. 2025;161:107177. PubMed
GIUNCO S, Del Mistro A, Morello M, Lidonnici J, et al From infection to immortality: The role of HPV and telomerase in head and neck
cancer.
Oral Oncol. 2025;161:107169. PubMedAbstract available
HANNA GJ, Zheng D, Gao W, Hair GM, et al PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell
carcinoma (R/M HNSCC) in the U.S.
Oral Oncol. 2025;161:107146. PubMedAbstract available
XU S, He J, Liu Z, Pei Y, et al Immune-related adverse events as prognostic biomarkers in recurrent or metastatic
nasopharyngeal carcinoma receiving PD-L1 inhibitor: A post-hoc analysis of the
multicenter, single-arm, phase 2 study.
Oral Oncol. 2025;161:107161. PubMedAbstract available
December 2024
KAOREY N, Dickinson K, Agnihotram VR, Zeitouni A, et al The role of ctDNA from liquid biopsy in predicting survival outcomes in
HPV-negative head and neck cancer: A meta-analysis.
Oral Oncol. 2024;161:107148. PubMedAbstract available
LIU Y, Fu N, Liu H, Su S, et al Corrigendum to "Risk factors of lymph node metastasis in the diffuse sclerosing
variant of papillary thyroid carcinoma compared with conventional papillary
thyroidcarcinoma in pediatric populations" [160 (2025) 107120/Article:OO_107120].
Oral Oncol. 2024 Dec 30:107135. doi: 10.1016/j.oraloncology.2024.107135. PubMed
DIETRICH N, Watson E, Tadic T, Martino R, et al Development of a prediction model for tube feeding dependence in HPV-associated
oropharyngeal cancer patients undergoing chemoradiotherapy.
Oral Oncol. 2024;161:107132. PubMedAbstract available
FANG Q, Yuan J, Zhang X, Dai L, et al Omitting elective neck dissection in cT1/2N0 oral squamous cell carcinoma with
sentinel lymph node metastasis: A prospective study.
Oral Oncol. 2024;161:107149. PubMedAbstract available
PRICE JM, Garcez K, Hughes C, Lee LW, et al The effect of time from surgery to commencing adjuvant radiotherapy for patients
with head and neck squamous cell carcinoma.
Oral Oncol. 2024;161:107138. PubMedAbstract available
STRUCKMEIER AK, Gosau M, Smeets R Immunotherapeutic strategies beyond the PD-1/PD-L1 pathway in head and neck
squamous cell carcinoma - A scoping review on current developments in agents
targeting TIM-3, TIGIT, LAG-3, and VISTA.
Oral Oncol. 2024;161:107145. PubMedAbstract available
MEGWALU UC, Ma Y, Divi V Association of race and ethnicity with quality of care among head and neck cancer
patients in California.
Oral Oncol. 2024;161:107144. PubMedAbstract available
PACE GM, Costantino A, De Virgilio A Comment on "Surgical, functional, and oncological outcomes of transoral robotic
surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review".
Oral Oncol. 2024;161:107142. PubMed
YU ST, Huang D, Xiong C, Xie R, et al Selperctinib as neoadjuvant therapy for RET-altered papillary thyroid carcinoma:
Two case reports.
Oral Oncol. 2024;161:107140. PubMedAbstract available
ALMEIDA ND, Yu H, Iovoli AJ, Fang M, et al Prophylactic gastrostomy tube during chemoradiation for head and neck cancer
decreases weight loss but increases rate of tube use beyond six months.
Oral Oncol. 2024;160:107136. PubMedAbstract available
DA MOTA SANTANA LA, Dos Santos Barreto M, Santos GA, Gopalsamy RG, et al Comment on "Time to treatment for head and neck cancer patients decreased during
the early phase of the COVID-19 pandemic".
Oral Oncol. 2024;160:107134. PubMed
PRACHA SH, Shrestha S, Ryan N, Upadhaya P, et al Targeting macrophage migration inhibitory factor to inhibit T cell
immunosuppression in the tumor microenvironment and improve cancer outcomes in
head and neck squamous cell carcinoma.
Oral Oncol. 2024;160:107126. PubMedAbstract available
LI H, Lou L, Du J, Li M, et al Multimodal profiling uncovers tertiary lymphoid structures as a critical
determinant of immunotherapy response and prognosis in nasopharyngeal carcinoma.
Oral Oncol. 2024;160:107129. PubMedAbstract available
SANKAR GANESH P, Naseef Pathoor N, Kanna Gopal R Letter to the editor regarding, "Impact of post-operative transoral robotic
surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal
squamous cell carcinoma".
Oral Oncol. 2024;159:107091. PubMedAbstract available
BALAJI H, Aithal VU, Varghese JJ, Devaraja K, et al Agreement between patient-reported and clinician-rated speech and swallowing
outcomes - Understanding the trend in post-operative oral cavity cancer patients.
Oral Oncol. 2024;159:107068. PubMedAbstract available
BALAGURU L, Hanubal KS, Galochkina Z, Lee JH, et al Surgical and functional outcomes after salvage oropharyngectomy.
Oral Oncol. 2024;159:107050. PubMedAbstract available
KORIC A, Chang CP, Hu S, Snyder J, et al Oral health-related quality of life among oropharyngeal cancer survivors.
Oral Oncol. 2024;159:107062. PubMedAbstract available
BOZKURT G, Turri Zanoni M, Ferrari M, Ioppi A, et al Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal
endoscopic nasopharyngectomy for advanced stage recurrent tumors.
Oral Oncol. 2024;159:107048. PubMedAbstract available
DANIELS KE, Awad DR, Liu SX, Mocharnuk J, et al Impact of post-operative transoral robotic surgery hemorrhage on adjuvant
treatment delays in patients with oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;159:107031. PubMedAbstract available
GREEN L, McDowell L, Ip F, Tapia M, et al Early return to work is possible after transoral robotic surgery (TORS) in
carefully selected patients with oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;159:107032. PubMedAbstract available
LU YT, Lin CW, Su SC, Ho YT, et al L48H37, a curcumin analog, suppresses matrix metalloproteinase-9 expression and
activity to hamper nasopharyngeal cancer cell migration.
Oral Oncol. 2024;159:107038. PubMedAbstract available
STAIBANO P, Au M, Xie M, Gupta MK, et al Return to work and self-reported swallowing following transoral robotic surgery
for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort
study.
Oral Oncol. 2024;159:107033. PubMedAbstract available
MORTAJA S, Chiumenti FA, Kalaskar DM, Dwivedi RC, et al Surgical complications and functional outcomes of 3191 jejunal free flaps used
for reconstruction of circumferential defects following head and neck cancer
resections: A systematic review.
Oral Oncol. 2024;160:107130. PubMedAbstract available
November 2024
MARRET G, Lamy C, Vacher S, Cabel L, et al Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic
resectable head and neck squamous cell carcinoma using circulating tumor DNA.
Oral Oncol. 2024;160:107111. PubMedAbstract available
JEYARAJ G Letter to the editor, "Loss of MACROD2 drives radioresistance but not cisplatin
resistance in HPV-positive head and neck cancer.".
Oral Oncol. 2024;160:107092. PubMed
LIU Y, Fu N, Liu H, Su S, et al Risk factors of lymph node metastasis in the diffuse sclerosing variant of
papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma
in pediatric populations.
Oral Oncol. 2024;160:107120. PubMedAbstract available
YAN C, Wang R, Zhang C, Lin G, et al Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy
and safety of the TPC regimen compared to GP and TPF.
Oral Oncol. 2024;160:107119. PubMedAbstract available
VON WITZLEBEN A, Grages A, Thomas J, Ezic J, et al Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent
on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing
analysis.
Oral Oncol. 2024;159:107107. PubMedAbstract available
LI S, Zhao T, Liu N, Li Y, et al Global research on oral cancer: A bibliometric analysis based on 82 highly cited
publications from 2014 to 2024.
Oral Oncol. 2024;159:107094. PubMedAbstract available
YANG B, Dai X, Li Z, Wu Z, et al Noninvasive surface-enhanced Raman spectroscopy outperforms combined positive
score in predicting sensitivity to neoadjuvant immunotherapy in head and neck
squamous cell carcinoma.
Oral Oncol. 2024;159:107105. PubMedAbstract available
RENGASAMY G, Priya Veeraraghavan V Using salivary DNA methylation to predict aging, cell changes, and protein levels
for assessing oral mucositis severity and survival in head and neck cancer
patients.
Oral Oncol. 2024;159:107086. PubMed
LEE YC, Hsin LJ, Lin WN, Fang TJ, et al Robot-assisted versus conventional neck dissection in head and neck cancers: A
systematic review and meta-analysis.
Oral Oncol. 2024;159:107101. PubMedAbstract available
MORGENTHALER J, Trommer M, Khor R, Wada M, et al Can we safely de-escalate HPV(+) oropharyngeal cancers? - A review of current
practices and novel approaches.
Oral Oncol. 2024;159:107089. PubMedAbstract available
LENNON SILVA CUNHA J In reply to "Risk of cardiovascular disease among head and neck cancer survivors:
A population-based matched cohort study".
Oral Oncol. 2024;159:107096. PubMed
TOPKAN E, Somay E, Ozturk D, Selek U, et al Commentary on "Effect analysis of 847 nasopharyngeal carcinoma cases treated with
intensity modulated radiation: Experience and suggestions".
Oral Oncol. 2024;159:107099. PubMed
SHANG K, Li T, Chen Y, Luo X, et al Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil
induction chemotherapy combined with locoregional radiotherapy in de novo
metastatic nasopharyngeal carcinoma: A single center prospective phase II
clinical trial.
Oral Oncol. 2024;159:107087. PubMedAbstract available
COSTANTINO A, Haughey B, Alamoudi U, Magnuson JS, et al Challenges in treating oropharyngeal cancer in the elderly: The role of transoral
surgery.
Oral Oncol. 2024;158:106996. PubMed
SOLARZ P, Mackiewicz-Nartowicz H, Sinkiewicz A, Burduk P, et al Results of CO2 laser surgery in laryngeal papillomatosis.
Oral Oncol. 2024;158:107004. PubMedAbstract available
ASHIQUE S, Houshyari M, Islam A, Pal R, et al The role of microbiota in nasopharyngeal cancer: Where do we stand?
Oral Oncol. 2024;158:106982. PubMedAbstract available
DE SENA COSTA DE OLIVEIRA D, Cunha JLS Comment on: Salivary DNA methylation derived estimates of biological aging,
cellular frequency, and protein expression as predictors of oral mucositis
severity and survival in head and neck cancer patients.
Oral Oncol. 2024;159:107097. PubMed
HIMANI Letter to the editor: Burden of oral cancer and associated risk factors at
national and state levels: A systematic analysis from the global burden of
disease in India, 1990-2021.
Oral Oncol. 2024;159:107093. PubMed
October 2024
MUTHAMIZH S, Balachandran S, Dilipan E Opinion on "Tumor habitat-based MRI features assessing early response in locally
advanced nasopharyngeal carcinoma".
Oral Oncol. 2024;159:107095. PubMed
LEHYANTI J, Even C, Fessart E, Wagner-Ballon C, et al Management of oligometastatic head and neck squamous cell carcinoma: A systematic
review.
Oral Oncol. 2024;159:107085. PubMedAbstract available
VILLARME A, Ebran N, Pace-Loscos T, Schiappa R, et al Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous
cell carcinomas.
Oral Oncol. 2024;159:107082. PubMedAbstract available
KARAMCHANDANI S, Sahovaler A, Crosbie-Jones E, McGurk M, et al Incidence and predictive factors for positive non-sentinel lymph nodes in
completion neck dissection following a positive sentinel node biopsy in early
oral cancer.
Oral Oncol. 2024;159:107081. PubMed
LI D, Lopez A, Shrivastava N, Chan W, et al Comprehensive functional evaluation of head and neck squamous cell carcinoma with
BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of
BH3-mimetics.
Oral Oncol. 2024;159:107069. PubMedAbstract available
WU WB, Xia L, Feng ZK, Liang JL, et al Characteristics and treatment of epistaxis in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107071. PubMedAbstract available
ZANG Y, Lu Y, Yu J, Dong Q, et al FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in
nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107066. PubMedAbstract available
GARSET-ZAMANI M, Lomholt AF, Charabi BW, Norling R, et al Surgeon-performed intraoperative transoral ultrasound improves the detection of
human papillomavirus-positive head and neck cancers of unknown primary.
Oral Oncol. 2024;159:107073. PubMedAbstract available
LIU C, Zhao H, Lu Y, Xia Y, et al Nomograms to predict occult contralateral central lymph node metastases in
unilateral papillary thyroid carcinoma with ipsilateral clinical lymph node
metastasis.
Oral Oncol. 2024;159:107051. PubMedAbstract available
SONG Y, Zhang Y, Bai Y, Wang T, et al Combination kinase inhibitors and immunotherapy for unresectable anaplastic
thyroid carcinoma: A retrospective single-center study.
Oral Oncol. 2024;159:107067. PubMedAbstract available
AWEEDA M, Richard K, Arnaud EH, Divi V, et al Factors influencing lymph node yield in head and neck squamous cell carcinoma: A
scoping review.
Oral Oncol. 2024;159:107070. PubMedAbstract available
HE SQ, Liu GY, Yu YH, Wang L, et al Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients
receiving immuno-chemotherapy: A multicenter, retrospective cohort study.
Oral Oncol. 2024;159:107074. PubMedAbstract available
LEE RH, Evans C, Alqasieer Y, Knott PD, et al Bite me: Can active biting during trismus therapy improve mouth opening in head
and neck cancer patients?
Oral Oncol. 2024;159:107064. PubMed
ZHAO BY, Hirayama S, Goss D, Zhao Y, et al Human papillomavirus-associated nasopharyngeal carcinoma: A systematic review and
meta-analysis.
Oral Oncol. 2024;159:107057. PubMedAbstract available
TANG WZ, Xu WZ, Liu TH Exploring the potential of gemcitabine, capecitabine, and tislelizumab after
anti-PD-1 treatment in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107065. PubMed
YACOUB I, Qian JY, Nashed K, Youssef M, et al Radiation techniques and advancements in nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107060. PubMed
GAUDIOSO P, Contro G, Taboni S, Costantino P, et al Intraoperative surgical navigation as a precision medicine tool in sinonasal and
craniofacial oncologic surgery.
Oral Oncol. 2024;157:106979. PubMedAbstract available
DAWSON A, Karimi AH, Shaikh MH, Gazala W, et al Loss of MACROD2 drives radioresistance but not cisplatin resistance in
HPV-positive head and neck cancer.
Oral Oncol. 2024;159:107061. PubMedAbstract available
AKASHANAND, Zahiruddin QS, Jena D, Ballal S, et al Burden of oral cancer and associated risk factors at national and state levels: A
systematic analysis from the global burden of disease in India, 1990-2021.
Oral Oncol. 2024;159:107063. PubMedAbstract available
September 2024
LECHIEN JR Surgical, Functional, and oncological outcomes of transoral robotic surgery for
cT1-T3 supraglottic laryngeal Cancers: A systematic review.
Oral Oncol. 2024;159:107047. PubMedAbstract available
KEEFE K, McCrary HC, Wei M, Mark B, et al Risk of cardiovascular disease among head and neck cancer survivors: A
population-based matched cohort study.
Oral Oncol. 2024;159:107041. PubMedAbstract available
DHARSHINI RAJATHIRAJAN S Commentary on "Salivary DNA methylation derived estimates of biological aging,
cellular frequency and protein expression as predictors of oral mucositis
severity and survival in head and neck cancer patients".
Oral Oncol. 2024;159:107053. PubMed
LYU W, Gong J, Zhu L, Xu T, et al MR radiomics unveils neoadjuvant chemo-responsiveness with insights into
selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.
Oral Oncol. 2024;159:107049. PubMedAbstract available
PRITHVIRAJ Comment on "Sexual Health, sexuality and sexual intimacy in patients with head
and neck cancer".
Oral Oncol. 2024;159:107054. PubMed
DINESHKUMAR R Letter to the editor: Risk factors associated with ototoxicity in long-term
survivors of nasopharyngeal carcinoma.
Oral Oncol. 2024;159:107052. PubMed
VALCENKO A, Zwick A, Schneider L, Linxweiler M, et al The tumor cell killing capacity of head and neck cancer patient-derived
neutrophils depends on tumor stage, gender and the antibody isotype.
Oral Oncol. 2024;159:107042. PubMedAbstract available
MIN Y, Liu X, Wei Z, Song G, et al Lung immune prognostic index is associated with clinical outcomes in recurrent or
metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from
the multicenter, single-arm, phase 2 study.
Oral Oncol. 2024;159:107028. PubMedAbstract available
RENGASAMY G, Priya Veeraraghavan V Comment on "The prognostic value of image-identified extranodal extension in
laryngeal and hypopharyngeal carcinoma following definitive (chemo-)
radiotherapy".
Oral Oncol. 2024;159:107035. PubMed
DHARSHINI RAJATHIRAJAN S Commentary on "Impact of high-risk EBV strains on nasopharyngeal carcinoma gene
expression.".
Oral Oncol. 2024;159:107037. PubMed
DHARSHINI RAJATHIRAJAN S Commentary on "Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant
metastasis and its correlation with PD-L1 expression in locoregionally advanced
nasopharyngeal carcinoma patients".
Oral Oncol. 2024;159:107036. PubMed
VERSCHOOR CP, Santi SA, Singh R, Tharmalingam S, et al Salivary DNA methylation derived estimates of biological aging, cellular
frequency and protein expression as predictors of oral mucositis severity and
survival in head and neck cancer patients.
Oral Oncol. 2024;159:107030. PubMedAbstract available
PAKA LUBAMBA G, Hua Y, Bao M, Zhang G, et al Variant of internal jugular vein reconstruction in bilateral radical neck
dissection.
Oral Oncol. 2024;159:107015. PubMedAbstract available
WANG A, Xia H, Li J, Diao P, et al Development of a novel prognostic signature derived from
super-enhancer-associated gene by machine learning in head and neck squamous cell
carcinoma.
Oral Oncol. 2024;159:107016. PubMedAbstract available
PRITHVIRAJ T Commentary on "Tumor Habitat-Based MRI features assessing early response in
locally advanced nasopharyngeal carcinoma".
Oral Oncol. 2024;159:107018. PubMed
XIAOYU J, Baihong P, Yaozhen L, Shen C, et al Preoperative protective stenting of the carotid artery in severe complex head and
neck cancer resection.
Oral Oncol. 2024;158:107012. PubMedAbstract available
PAYNE K, Suriyanarayanan H, Brooks J, Mehanna H, et al Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free
DNA methylation and copy number in head and neck squamous cell carcinoma.
Oral Oncol. 2024;158:107011. PubMedAbstract available
ZHANG X, Zheng W, Huang S, Li H, et al Xerostomia prediction in patients with nasopharyngeal carcinoma during
radiotherapy using segmental dose distribution in dosiomics and radiomics models.
Oral Oncol. 2024;158:107000. PubMedAbstract available
CHEN J, Cheng H, Liang Y, Lin J, et al The efficacy of adjuvant chemotherapy in patients with different
midpoint-radiotherapy Epstein-Barr virus DNA plasma loads.
Oral Oncol. 2024;156:106938. PubMedAbstract available
August 2024
LECHIEN JR, Hans S Survival, Surgical, and functional outcomes of transoral laser microsurgery for
cT1-T3 supraglottic laryngeal Cancers: A systematic review.
Oral Oncol. 2024;158:107009. PubMedAbstract available
ZHAO J, Ruan X, Wei S, Zheng X, et al The first report of bilateral parapharyngeal lymph node metastasis from papillary
thyroid carcinoma: A case report.
Oral Oncol. 2024;158:107006. PubMed
YIN WJ, Mao W, Yang F, Wang MY, et al Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity
modulated radiation: Experience and suggestions.
Oral Oncol. 2024;158:107001. PubMedAbstract available
GE Y, Liu H, Huang W, Zhu H, et al Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1(hi) and EGR3
positive B cells in the nasopharyngeal carcinoma microenvironment.
Oral Oncol. 2024;158:106999. PubMedAbstract available
T P Commentary on "Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in
recurrent/metastatic head and neck squamous cell carcinoma (r/mHNSCC)".
Oral Oncol. 2024;158:107010. PubMed
ZHOU X, Shao T, Jia H, Hou L, et al Current state, challenges, and future perspective of adaptive radiotherapy: A
narrative review of nasopharyngeal carcinoma.
Oral Oncol. 2024;158:107008. PubMedAbstract available
PRASAD M DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic
Implications in Oral Cancer.
Oral Oncol. 2024 Aug 23:106995. doi: 10.1016/j.oraloncology.2024.106995. PubMed
KNAP RABJERG H, Grau Eriksen J, Soby S Impact of antibiotics on PD-1 inhibition in recurrent/metastatic head and neck
squamous cell carcinoma.
Oral Oncol. 2024;158:107003. PubMed
DU F, Shao K, Yang Y, Bai X, et al Comparative dosimetric analysis of normal brain tissue in patients with
Nasopharyngeal carcinoma at different stages after radiation therapy.
Oral Oncol. 2024;158:106998. PubMedAbstract available
ALSHEIKH S, Su J, O'Sullivan B, Ringash J, et al The prognostic value of image-identified extranodal extension in laryngeal and
hypopharyngeal carcinoma following definitive (chemo-)radiotherapy.
Oral Oncol. 2024;158:107007. PubMedAbstract available
SUN L, Cohen RB, Dimitrios Colevas A Platinum/taxane/pembrolizumab vs platinum/5FU/pembrolizumab in
recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC).
Oral Oncol. 2024;158:106997. PubMedAbstract available
HANNA GJ, Jabalee J, Lukens JN, Sun L, et al Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic
HPV-driven oropharyngeal cancer.
Oral Oncol. 2024;158:107002. PubMedAbstract available
YUAN J, Wu M, Qiu L, Xu W, et al Tumor habitat-based MRI features assessing early response in locally advanced
nasopharyngeal carcinoma.
Oral Oncol. 2024;158:106980. PubMedAbstract available
YANG R, Li R, Niu X, Zhao Y, et al Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic
nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A
retrospective study.
Oral Oncol. 2024;158:106981. PubMedAbstract available
HUSSEIN NI, Molina AH, Sunga GM, Amit M, et al Localized intratumoral delivery of immunomodulators for oral cancer and oral
potentially malignant disorders.
Oral Oncol. 2024;158:106986. PubMedAbstract available
PAN GS, Sun XM, Kong FF, Wang JZ, et al Delta magnetic resonance imaging radiomics features?based nomogram predicts
long?term efficacy after induction chemotherapy in locoregionally advanced
nasopharyngeal carcinoma.
Oral Oncol. 2024;157:106987. PubMedAbstract available
QIN G, Liao X, Zhang B, Su Y, et al An individualized immune prognostic signature in nasopharyngeal carcinoma.
Oral Oncol. 2024;157:106985. PubMedAbstract available
TAMIOLAKIS P, Shah A, Dawson R, Ramasamy S, et al HPV- associated sinonasal squamous cell carcinoma with FGFR3::TACC3 fusion. A
rare case report.
Oral Oncol. 2024;157:106983. PubMedAbstract available
SHIMIZU H, Kodaira T, Kiyota N, Hayashi R, et al Incidence and risk factors associated with the development of hypothyroidism
after postoperative chemoradiotherapy for head and neck cancer patients with
high-risk features: Supplementary analysis of JCOG1008.
Oral Oncol. 2024;157:106976. PubMedAbstract available
SANKAR S Letter to editor regarding "Impact of high-risk EBV strains on nasopharyngeal
carcinoma gene expression".
Oral Oncol. 2024;157:106977. PubMed
SCHAEFFERS AWMA, Scholten HA, van Beers MA, Meussen BW, et al The effect of skeletal muscle mass on dose-limiting toxicities during
(chemo)radiotherapy in patients with head and neck cancer: A systematic review
and meta-analysis.
Oral Oncol. 2024;157:106978. PubMedAbstract available
July 2024
MCDOWELL L, Gough K, White I, Corry J, et al Sexual Health, sexuality and sexual intimacy in patients with head and neck
cancer - A narrative review.
Oral Oncol. 2024;157:106975. PubMedAbstract available
DAS S, Ghosh Laskar S, V Kane S, D'Cruz AK, et al Adjuvant therapy for intermediate risk factors in oral cancer: Can we reach a
consensus?
Oral Oncol. 2024;157:106972. PubMedAbstract available
JEYARAJ G Letter to the editor, "Clinical benefits of combining oral cytotoxic
chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous
cell carcinoma based on the reports of the head and neck Cancer Registry of
Japan.".
Oral Oncol. 2024;157:106974. PubMed
JEYARAJ G Letter to the editor, "Mutation detection in saliva from oral cancer patients".
Oral Oncol. 2024;157:106929. PubMed
GANESH PS, Pathoor NN, Gopal RK Letter to the editor regarding "Induction chemotherapy regimes in first-line
treatment for locoregionally advanced nasopharyngeal carcinoma: A network
meta-analysis and cost-effectiveness analysis.
Oral Oncol. 2024;157:106954. PubMedAbstract available
LORINI L, Zigliani G, Morbini P, Salviato E, et al Expression of PDL-1 between primary and recurrent/metastatic head and neck
squamous cell carcinoma: A bi-institutional retrospective concordance analysis
(CONCORDL-1 study).
Oral Oncol. 2024;157:106950. PubMedAbstract available
JEYACHANDRAN S Comment on, "Characterization of oral microbiota in HPV and non-HPV head and neck
squamous cell carcinoma and its association with patient outcomes".
Oral Oncol. 2024;157:106973. PubMedAbstract available
SURESH S Comment on: An algorithm for standardization of tumor infiltrating lymphocyte
evaluation in head and neck cancers.
Oral Oncol. 2024;157:106959. PubMed
WEN YF, Huang WJ, Chen XL, Cai HT, et al Predictive value of CXCL1(+)_FAP(+) phenotype in CAFs for distant metastasis and
its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal
carcinoma patients.
Oral Oncol. 2024;157:106963. PubMedAbstract available
ICHISAKA T, Sano D, Kijima N, Kawakita D, et al Clinical benefits of combining oral cytotoxic chemotherapeutic agents with
radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the
reports of the Head and Neck Cancer Registry of Japan.
Oral Oncol. 2024;157:106942. PubMedAbstract available
TINO R, Roach MA, Fuentes GD, Agrawal A, et al Development and clinical implementation of a digital workflow utilizing
3D-printed oral stents for patients with head and neck cancer receiving
radiotherapy.
Oral Oncol. 2024;157:106944. PubMedAbstract available
LIM CY, Ng GWY, Goh CK, Lee MKC, et al Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression.
Oral Oncol. 2024;157:106941. PubMedAbstract available
SHANMUGAM G Letter to the editor, "The prognostic value of pretreatment (18)F-FDG PET-CT
parameters with peripheral blood markers in patients with de novo metastatic
nasopharyngeal carcinoma.".
Oral Oncol. 2024;157:106951. PubMed
MEIVELU MOOVENDHAN "Letter to the Editor: Next-Generation sequencing (NGS) profiling of matched
tumor and Circulating Tumor DNA (ctDNA) in Head and Neck Squamous Cell Carcinoma
(HNSCC)".
Oral Oncol. 2024;157:106940. PubMed
ZENGA J, Himburg HA, Wong SJ, Kearl T, et al In silico identification of public neo-antigens in head and neck Cancer for T
cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations.
Oral Oncol. 2024 Jul 14:106947. doi: 10.1016/j.oraloncology.2024.106947. PubMed
DHARMALINGAM JOTHINATHAN MK Letter to the Editor, "Immunochemotherapy alone or immunochemotherapy plus
subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal
carcinoma".
Oral Oncol. 2024;156:106948. PubMed
SHANMUGAM G Commentary on, "Final analysis of a phase II trial of neoadjuvant
chemoimmunotherapy for locoregionally advanced head and neck squamous cell
carcinoma.".
Oral Oncol. 2024;156:106952. PubMed
PIYARATHNE NS, Liyanage SN, Rasnayaka RMSGK, Hettiarachchi PVKS, et al A comprehensive dataset of annotated oral cavity images for diagnosis of oral
cancer and oral potentially malignant disorders.
Oral Oncol. 2024;156:106946. PubMedAbstract available
MAHDI AGM Knowledge, and attitude of medical students about role of human papilloma virus,
and vaccine in head and neck cancer.
Oral Oncol. 2024;156:106939. PubMedAbstract available
SHANMUGAM G Letter to the editor, "Letter to the editor, "Short-term versus long-term
metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A
propensity score-matched real-world study.".
Oral Oncol. 2024;156:106935. PubMed
ARUMUGANAINAR D, Sekaran S Correspondence on "Global burdens of nasopharyngeal carcinoma in children and
young adults: Trends and predictions to 2040".
Oral Oncol. 2024;156:106933. PubMed
GU LW, Zhang X, Zhang J, Xiao BB, et al The prognostic value of pretreatment (18)F-FDG PET-CT parameters with peripheral
blood markers in patients with de novo metastatic nasopharyngeal carcinoma.
Oral Oncol. 2024;156:106928. PubMedAbstract available
SURESH S Commentary on 'Mutation detection in saliva from oral cancer patients'.
Oral Oncol. 2024;156:106937. PubMed
KASIRAJAN H, Rengasamy G, Priya Veeraraghavan V Comment on the "Quality of life in 583 head and neck cancer survivors assessed
with the FACE-Q head and neck cancer module".
Oral Oncol. 2024;156:106934. PubMed
KANNAN R Comments on: Human Papilloma Virus vaccine and prevention of head and neck
cancer, what is the current evidence?
Oral Oncol. 2024;156:106936. PubMed
DAUNGSUPAWONG H, Wiwanitkit V Letter to the Editor on "Utility of TTMV-HPV DNA in resolving indeterminate
findings during oropharyngeal cancer surveillance".
Oral Oncol. 2024;156:106930. PubMed
LIOKATIS P, Liokati I, Obermeier K, Smolka W, et al Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A
systematic review.
Oral Oncol. 2024;154:106808. PubMedAbstract available
CHEN AM Translational risk-adapted approaches to de-escalated radiation for human
papillomavirus-positive oropharyngeal cancer: Past, present, and future.
Oral Oncol. 2024;154:106850. PubMedAbstract available
SATHISHKUMAR K Letter to the editor "risk prediction model for cisplatin-induced acute kidney
injury in patients with head and neck cancer receiving chemoradiotherapy: A
re-analysis of a phase II/III JCOG1008 trial ".
Oral Oncol. 2024;156:106931. PubMed
HARIDEVAMUTHU B Letter to the Editor: "Exploring long-term responses to immune checkpoint
inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma".
Oral Oncol. 2024;156:106913. PubMed
June 2024
BENJAMIN WJ, Feng AL, Heft Neal M, Bellile E, et al Utility of bioselection with neoadjuvant chemotherapy for organ preservation in
patients with T4 laryngeal cancer.
Oral Oncol. 2024;156:106917. PubMedAbstract available
ZHAO X, Zhou Y, Peng G, Wen L, et al Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for
locoregionally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2024;156:106918. PubMedAbstract available
SARAVANAN M, Singh Carmelin D, Mohanprasanth A, Arockiaraj J, et al Comment on "Oral microbiome and risk of incident head and neck cancer: A nested
case-control study".
Oral Oncol. 2024;156:106911. PubMed
POONGAVANAM SS, Behera A, Dharmalingam Jothinathan MK Letter to the editor, "Proton therapy re-irradiation outcomes and genomic
landscape of patients with recurrent head and neck cancer".
Oral Oncol. 2024;156:106912. PubMed
JEYARAJ G Letter to the editor, "Immune infiltration at the primary tumor is associated
with clinical outcome of patients with extranodal extension of lymph node
metastasis in oral cancer".
Oral Oncol. 2024;156:106906. PubMed
DONG S, Bei W, Lin L, Jiang Y, et al Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced
nasopharyngeal carcinoma: A propensity score-matched real-world study.
Oral Oncol. 2024;156:106908. PubMedAbstract available
JEYARAJ G Transformative impact of 3D-Printed implants and Virtual surgical planning in
oral cancer reconstruction.
Oral Oncol. 2024;156:106896. PubMed
SHANMUGAM G Letter to the editor, "Proton therapy re-irradiation outcomes and genomic
landscape of patients with recurrent head and neck cancer.".
Oral Oncol. 2024;156:106915. PubMed
BASTIEN AJ, Ng J, Cong I, Garcia J, et al Patient perceptions underlying ctDNA molecular surveillance for HPV(+)
oropharyngeal squamous cell carcinoma.
Oral Oncol. 2024;156:106894. PubMedAbstract available
HARIDEVAMUTHU B Letter to the Editor: "Immune infiltration at the primary tumor is associated
with clinical outcome of patients with extranodal extension of lymph node
metastasis in oral Cancer".
Oral Oncol. 2024;155:106902. PubMed
MEIVELU MOOVENDHAN Letter to the editor, "Gut microbiome predicts gastrointestinal toxicity outcomes
from chemoradiation therapy in patients with head and neck squamous cell
carcinoma".
Oral Oncol. 2024;155:106903. PubMed
PRASAD M, Sekar R, Murugan R Letter to editor on "Proton therapy re-irradiation outcomes and genomic landscape
of patients with recurrent head and neck cancer".
Oral Oncol. 2024;155:106899. PubMed
SELVI POONGAVANAM S, Behera A, Kumar Dharmalingam Jothinathan M Letter to the Editor, "The predictive role of PD-L1 in head and neck Cancer: A
systematic review and Meta-Analysis".
Oral Oncol. 2024;155:106904. PubMed
TOPKAN E, Somay E, Bascil S, Selek U, et al Comment on prospective comparison of acute severe toxicities between smokers and
non-smokers during radiotherapy for head and neck cancers.
Oral Oncol. 2024;155:106898. PubMed
HARIDEVAMUTHU B Genomic instability in HPV-positive oropharyngeal squamous cell carcinoma: The
role of integration sites in treatment response.
Oral Oncol. 2024;155:106895. PubMed
LEI S, Chen L, Ji P, Li K, et al Global burdens of nasopharyngeal carcinoma in children and young adults and
predictions to 2040.
Oral Oncol. 2024;155:106891. PubMedAbstract available
DA MOTA SANTANA LA, Simoes JMD, Santos GA, Gopalsamy RG, et al Comment on "Association between COVID 19 exposure and expression of malignant
pathological features in oral cancer: A retrospective cohort study".
Oral Oncol. 2024;155:106877. PubMed
ROOF SA, Jabalee J, Rettig EM, Chennareddy S, et al Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal
cancer surveillance.
Oral Oncol. 2024;155:106874. PubMedAbstract available
FERRARI M, Mularoni F, Taboni S, Crosetti E, et al Corrigendum to "How reliable is assessment of true vocal cord-arytenoid unit
mobility in patients affected by laryngeal cancer? a multi-institutional study on
366 patients from the ARYFIX collaborative group" [Oral Oncol. 152C (2024)
106744].
Oral Oncol. 2024 Jun 8:106887. doi: 10.1016/j.oraloncology.2024.106887. PubMed
PRASAD M, Murugan R Comment on "The circadian clock gene, BMAL1, promotes radiosensitization in
nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition
via the TGF-beta1/Smads/Snail1 axis".
Oral Oncol. 2024;155:106890. PubMed
TASOULAS J, Adams GJ, Schrank TP, Agala CB, et al Time to treatment for head and neck cancer patients decreased during the early
phase of the Covid-19 pandemic.
Oral Oncol. 2024;155:106879. PubMed
DHARMALINGAM JOTHINATHAN MK Letter to the Editor, "How reliable is assessment of true vocal cord-arytenoid
unit mobility in patients affected by laryngeal cancer? A multi-institutional
study on 366 patients from the ARYFIX collaborative group".
Oral Oncol. 2024;155:106878. PubMed
BABU S, Krishnan M Human papillomavirus and oropharyngeal cancer in HNSCC: A growing concern.
Oral Oncol. 2024;153:106824. PubMed
PACE GM, Costantino A, Festa BM, Spriano G, et al Oropharyngeal squamous cell carcinoma: Treatment (de-) intensification?
Oral Oncol. 2024;153:106299. PubMed
LU HA, Wang YM, Chih Chen W, Wu CN, et al Post-irradiation dysbiosis in patients with nasopharyngeal carcinoma having
received radiotherapy - A pilot study.
Oral Oncol. 2024;154:106864. PubMedAbstract available
KRC R, Mendes W, Molitoris J, Ferris M, et al Proton therapy re-irradiation outcomes and genomic landscape of patients with
recurrent head and neck cancer.
Oral Oncol. 2024;154:106875. PubMedAbstract available
May 2024
XU W, Qiu L, Li F, Fei Y, et al Induction chemotherapy regimes in first-line treatment for locoregionally
advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness
analysis.
Oral Oncol. 2024;154:106865. PubMedAbstract available
IMAMURA Y, Kiyota N, Tahara M, Kodaira T, et al Risk prediction model for cisplatin-induced acute kidney injury in patients with
head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III
JCOG1008 trial.
Oral Oncol. 2024;154:106868. PubMedAbstract available
PARK R, Li J, Slebos RJC, Chaudhary R, et al Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or
metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2024;154:106866. PubMedAbstract available
SARAVANAN M, Carmelin DS, Mohanprasanth A, Arockiaraj J, et al Comment on "Oral microbiome and risk of incident head and neck cancer: A nested
case-control study".
Oral Oncol. 2024;154:106858. PubMed
HESHAM A, David Kim D, Alshamrani Y, AlOtaibi F, et al The efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy in
recurrent head and neck squamous cell carcinoma. Report of a case and review of
the literature.
Oral Oncol. 2024;154:106863. PubMed
ABBACI M, Villard A, Auperin A, Asmandar S, et al Ultra-fast confocal fluorescence microscopy for neck lymph node imaging in head
and neck cancer.
Oral Oncol. 2024;154:106862. PubMedAbstract available
YAO Y, Ouyang Q, Wang S, Li K, et al Incorporation of PD-1 blockade into induction chemotherapy improved tumor
response in patients with locoregionally advanced nasopharyngeal carcinoma in a
retrospective patient cohort.
Oral Oncol. 2024;154:106867. PubMedAbstract available
RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al In response to the reply on 'Advancing oral cancer diagnosis in Brazil:
Integrating artificial intelligence with teledentistry for enhanced patient
outcomes'.
Oral Oncol. 2024;154:106856. PubMed
COSTANTINO A, Haughey B, Zhu J, Mekhail T, et al Sinonasal squamous cell carcinoma in the United States: Temporal and geographic
patterns associated with HPV testing and positivity.
Oral Oncol. 2024;154:106855. PubMedAbstract available
PEZZULLA D, Re A, Ferro M, Cilla S, et al Lower cranial nerve palsy after hypofractionated radiotherapy in a laryngeal
cancer patient: A letter to the editor.
Oral Oncol. 2024;154:106837. PubMed
ALVES DA MOTA SANTANA L, Gois Floresta L, Maciel Alves EV, Ribeiro Couto G, et al Reply to: Comment on "Advancing oral cancer diagnosis in Brazil: Integrating
artificial intelligence with teledentistry for enhanced patient outcomes".
Oral Oncol. 2024;154:106840. PubMed
HE S, Yu H, He L, Liu M, et al Risk factors associated with ototoxicity in long-term nasopharyngeal carcinoma
survivors.
Oral Oncol. 2024;154:106827. PubMedAbstract available
VAZQUEZ FL, Coracin FL, Arantes KLBF, Ferigatto JL, et al An oral cancer screening program in Brazil: Analysis of seven years of outcome
after its implementation in the suburban cities of Sao Paulo.
Oral Oncol. 2024;154:106826. PubMedAbstract available
DE FELICE F, Guerrero Urbano T Lower-neck sparing in patients with uninvolved neck nasopharyngeal carcinoma:
Unquestioned benefit?
Oral Oncol. 2024;154:106836. PubMed
HAN N, Zhou D, Ruan M, Yan M, et al Corrigendum to "Cancer cell-derived extracellular vesicles drive pre-metastatic
niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on
FRCs in head and neck cancer" [Oral Oncol. 145 (2023) 106524].
Oral Oncol. 2024 May 9:106831. doi: 10.1016/j.oraloncology.2024.106831. PubMed
INVERNIZZI C, Da Silva Ribeiro Mota A, Barbe C, Bouazzi L, et al Prospective comparison of acute severe toxicities between smokers and non-smokers
during radiotherapy for head and neck cancers.
Oral Oncol. 2024;153:106833. PubMedAbstract available
PADERNO A, Petrelli F, Lorini L, Capriotti V, et al The predictive role of PD-L1 in head and neck cancer: A systematic review and
meta-analysis.
Oral Oncol. 2024;153:106799. PubMedAbstract available
LIU Y, Zuo ZC, Zeng XY, Ma J, et al Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision
tree classification: A multicenter retrospective study.
Oral Oncol. 2024;153:106834. PubMedAbstract available
XU Y, Xu T, Yao Q, Chen J, et al Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
Oral Oncol. 2024;153:106828. PubMedAbstract available
ALMANGUSH A, Makitie AA, Leivo I Assessment of tumor-infiltrating lymphocytes in head and neck cancer: Clinical
scenarios.
Oral Oncol. 2024;153:106829. PubMed
DAS R, Misra SR Author's reply to comment on "awareness regarding oral cancer amongst the dental,
medical, and nursing students: Is something lacking?".
Oral Oncol. 2024;153:106832. PubMed
DHARMALINGAM JOTHINATHAN MK Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell
carcinoma with low rates of adjuvant therapy: A consecutive single-institution
study from 2013 to 2020.
Oral Oncol. 2024;152:106811. PubMed
POOJARI M, Madabhavi I, Desai S Extraskeletal Ewing's sarcoma of supraglottis: A rare case report.
Oral Oncol. 2024;152:106789. PubMedAbstract available
MELDGAARD JUSTESEN M, Kronberg Jakobsen K, Fenger Carlander AL, Hjordt Holm Larsen M, et al Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell
carcinoma with low rates of adjuvant therapy: A consecutive single-institution
study from 2013 to 2020.
Oral Oncol. 2024;152:106783. PubMedAbstract available
April 2024
TONSBEEK AM, Hundepool CA, Roubos J, Rijken B, et al Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q
head and neck cancer module.
Oral Oncol. 2024;153:106813. PubMedAbstract available
MICHIKAWA C, Gleber-Netto FO, Pickering CR, Rao X, et al Immune infiltration at the primary tumor is associated with clinical outcome of
patients with extranodal extension of lymph node metastasis in oral cancer.
Oral Oncol. 2024;153:106729. PubMedAbstract available
FANG Q, Yuan J, Zhang X, Dai L, et al Oncologic and functional results between sentinel lymph node biopsy and elective
neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Oral Oncol. 2024;152:106810. PubMedAbstract available
YEO BSY, Lee RS, Lim NE, Tan E, et al Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or
Metastatic Nasopharyngeal Carcinoma - A Systematic Review and Meta-analysis.
Oral Oncol. 2024;152:106786. PubMedAbstract available
LI Y, Zhou Y, Zhao C, Liu L, et al The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal
carcinoma by inhibiting the epithelial-to-mesenchymal transition via the
TGF-beta1/Smads/Snail1 axis.
Oral Oncol. 2024;152:106798. PubMedAbstract available
RAMASAMY P, Sekaran S, Ganapathy D Oral cancer burden in tribal populations residing in India.
Oral Oncol. 2024;152:106801. PubMed
SEKAR D Comment on betel-nut chewing does not influence PD-L1 expression rates in
recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective
biomarker prevalence study.
Oral Oncol. 2024;152:106800. PubMed
SARAVANAN M Comment on "Nanomedicine, an emerging therapeutic strategy for oral cancer
therapy".
Oral Oncol. 2024;152:106806. PubMed
RICARDO ELIAS DE MELO P, Agra Monteiro M, Henrique Rocha Aragao H, Vitoria de Araujo Lopes N, et al Comment on "Awareness regarding oral cancer amongst the dental, medical, and
nursing students: Is something lacking?".
Oral Oncol. 2024;152:106802. PubMed
SMITH JD, Heft-Neal ME, Rosko AJ, Chepeha DB, et al Upfront neck dissection to guide single-modality therapy for early stage
supraglottic squamous cell carcinoma.
Oral Oncol. 2024;152:106803. PubMed
KONO M, Saito S, Rokugo M, Egloff AM, et al Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy
in head and neck cancer.
Oral Oncol. 2024;152:106795. PubMedAbstract available
SEGNA E, Civita F, Denaro N, Beltramini GA, et al Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell
cancer.
Oral Oncol. 2024;152:106784. PubMedAbstract available
SIVAPERUMAL P, Ganapathy D, Kamala K Revolutionizing oral cancer treatment: Harnessing the potential of adaptive
CARneg T cell therapy.
Oral Oncol. 2024;152:106794. PubMed
RAJAKUMAR HK, Coimbatore Sathyabal V, Vivekanandam A, Nasrin Jabarulla K, et al Evaluation of nuclear morphometry in exfoliative cytology of buccal mucosa in
patients with high risk of oral cancer.
Oral Oncol. 2024;152:106793. PubMedAbstract available
SARAVANAN M Comment on "The microbiome and oral cancer: More questions than answers".
Oral Oncol. 2024;152:106792. PubMed
ARAGAO HHR, Monteiro MA, Lopes NVA, Cunha JLS, et al Comment on "Betel-nut chewing does not influence PD-L1 expression rates in
recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective
biomarker prevalence study".
Oral Oncol. 2024;152:106788. PubMed
DAS R, Misra SR, Nayak A Awareness regarding oral cancer amongst the dental, medical, and nursing
students: Is something lacking?
Oral Oncol. 2024;152:106790. PubMed
XIAO X, Shi Z, Song Z Comment on circulatory mitochondrial DNA as a novel biomarker for head and neck
cancers.
Oral Oncol. 2024;152:106785. PubMed
GASNE C, Atallah S, Dauzier E, Thariat J, et al Twelve years after: The french national network on rare head and neck tumours
(REFCOR).
Oral Oncol. 2024;151:106762. PubMedAbstract available
MALI SB Role of telemedicine in head neck cancer.
Oral Oncol. 2024;151:106746. PubMedAbstract available
MIRIMOGHADDAM M, Bohlouli B, Lai H, Viegas S, et al Trends and predictors of unplanned hospitalization among oral and oropharyngeal
cancer patients; an 8-year population-based study.
Oral Oncol. 2024;151:106742. PubMedAbstract available
March 2024
MEGAHED R, Prabhu AV, Mack DP, Gholami S, et al Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate
radiotherapy: An institutional series.
Oral Oncol. 2024;152:106778. PubMedAbstract available
LORINI L, Gili R, Salvestrini V, Morelli I, et al De novo metastatic head and neck squamous cell carcinoma: Why does locoregional
control "always" matter?
Oral Oncol. 2024;152:106768. PubMedAbstract available
XIROU V, Moutafi M, Bai Y, Nwe Aung T, et al An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in
head and neck cancers.
Oral Oncol. 2024;152:106750. PubMedAbstract available
HONG RL, Yen CJ, Lien MY, Cheng R, et al Betel-nut chewing does not influence PD-L1 expression rates in
recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective
biomarker prevalence study.
Oral Oncol. 2024;152:106760. PubMedAbstract available
FERRARI M, Mularoni F, Taboni S, Crosetti E, et al How reliable is assessment of true vocal cord-arytenoid unit mobility in patients
affected by laryngeal cancer? a multi-institutional study on 366 patients from
the ARYFIX collaborative group.
Oral Oncol. 2024;152:106744. PubMedAbstract available
TOYA R, Fukugawa Y, Saito T, Matsuyama T, et al Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric
modulated arc therapy for incurable head and neck cancer.
Oral Oncol. 2024;151:106752. PubMedAbstract available
RUIZ-TORRES DA, Naegele S, Podury A, Wirth L, et al Immunotherapy time of infusion impacts survival in head and neck cancer: A
propensity score matched analysis.
Oral Oncol. 2024;151:106761. PubMedAbstract available
SIMON L, Paly J, Park E, Samuels-Kalow M, et al Medicare dental coverage for patients with head and neck cancer: An opportunity
in need of advocates.
Oral Oncol. 2024 Mar 15:106754. doi: 10.1016/j.oraloncology.2024.106754. PubMed
RICARDO ELIAS DE MELO P, Agra Monteiro M, Vitoria de Araujo Lopes N, Silva Cunha JL, et al Comment on "advancing oral cancer diagnosis in Brazil: Integrating artificial
intelligence with Teledentistry for Better Patient Outcomes".
Oral Oncol. 2024;151:106758. PubMed
RAJANATHADURAI J, Sindya J, Madar IH, Perumal E, et al Exosomal immune checkpoint protein (PD-L1): Hidden player in PD-1/PD-L1 blockade
immunotherapy resistance in oral cancer.
Oral Oncol. 2024;151:106748. PubMed
ZUPANCIC M, Kostopoulou ON, Holzhauser S, Lukoseviciute M, et al Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA
positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ
significantly between various subsites or correlate to survival.
Oral Oncol. 2024;151:106749. PubMedAbstract available
FERRARO T, Pershad AR, Arora S, Lee E, et al The utility of ultrasonographic surveillance in management of a presumed
branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer.
Oral Oncol. 2024;151:106743. PubMedAbstract available
KIM DH, Lim ST, Kim HR, Kang EJ, et al Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab
efficacy in patients with head and neck squamous cell carcinoma: Post hoc
analysis of TRIUMPH study.
Oral Oncol. 2024;151:106739. PubMedAbstract available
SANTANA LADM, Floresta LG, Alves EVM, Melo LMR, et al Advancing oral cancer diagnosis in Brazil: Integrating artificial intelligence
with teledentistry for enhanced patient outcomes.
Oral Oncol. 2024;151:106741. PubMed
CHEN K, Shi M, Mo S, Liu T, et al Clinical features and prognostic factors of nasopharyngeal carcinoma with brain
metastases.
Oral Oncol. 2024;151:106738. PubMedAbstract available
DING C, Dai DY, Luo ZK, Wang GY, et al Evaluation of a novel model incorporating serological indicators into the
conventional TNM staging system for nasopharyngeal carcinoma.
Oral Oncol. 2024;151:106725. PubMedAbstract available
LU X, Zhang JL, Zhai X, Liu Q, et al A case report on a nasal and oral cavity involving large solitary fibrous tumor
and comprehensive review of case literature.
Oral Oncol. 2024;150:106715. PubMedAbstract available
YOUNG RJ, Angel C, Bressel M, Pizzolla A, et al Characterising B cell expression and prognostic significance in human
papillomavirus positive oropharyngeal cancer.
Oral Oncol. 2024;150:106687. PubMedAbstract available
February 2024
VAN SCHAIK JE, van der Vegt B, Slagter-Menkema L, van der Laan BFAM, et al Identification of new head and neck squamous cell carcinoma molecular imaging
targets.
Oral Oncol. 2024;151:106736. PubMedAbstract available
MELACHURI M, Kurukulasuriya C, Rumde P, Patel T, et al Treatment package time < 14 weeks improves recurrence free and disease specific
survival in HPV positive OPC with high-risk features.
Oral Oncol. 2024;151:106703. PubMedAbstract available
AHMED AA, Sborchia M, Bye H, Roman-Escorza M, et al Mutation detection in saliva from oral cancer patients.
Oral Oncol. 2024;151:106717. PubMedAbstract available